OTCQB: LXXGF | TSX.V: LXG

  • Company
    • Our Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
    • Join Our Team
    • News Releases
    • In the Media
    • Upcoming Events
  • Investors
    • Presentations
    • Financials
    • Share Structure
    • Stock Information
    • Investor Events
    • Investor Inquiries
  • Markets
    • Biologics Manufacturing
    • Veterinary Diagnostics
  • Products
    • MiQLab® System
    • Assay Panels
    • Request Product Information
    • I’d Like a Demonstration
  • Resources
  • Our Blog
  • Contact
    • Contact
    • Investor Inquiries
    • Support
    • Product Information
    • Subscribe for Updates
A Guide to Common Sterile Processing Contaminants

A Guide to Common Sterile Processing Contaminants

by Chris Bartlett | Mar 2, 2022 | Biologics Manufacturing

Cleanroom Technology Feb. 22 article: we will explore a handful of common bioreactors and cleanroom organisms in terms of why they are able to proliferate and persist despite thorough Quality by Design (QbD) developed methods of production.

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

by LexaGene | Feb 1, 2022 | Veterinary Diagnostics

Dr. Jack Regan, CEO and Founder of LexaGene gives an update to BioPub Investment group on January 26, 2021.

Pathogen Detection and Biodefense on the Finding Genius Podcast

Pathogen Detection and Biodefense on the Finding Genius Podcast

by LexaGene | Oct 1, 2021 | Human Clinical Diagnostics

Dr. Jack Regan, CEO of LexaGene, shares his work identifying the future biothreats human and veterinary populations may face.

LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats

LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats

by LexaGene | Sep 16, 2021 | Biothreat Detection

GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army.

Four Key Insights for Preventing the Next Pandemic

Four Key Insights for Preventing the Next Pandemic

by LexaGene | Jul 22, 2021 | Human Clinical Diagnostics

In the latest issue of the Pathologist, Dr. Jack Regan discusses the strategic priorities and technologies that could prevent the next global pandemic:

« Older Entries
Next Entries »

Press Releases

  • Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology May 25, 2022
  • The Dawn of the Superbugs May 10, 2022
  • LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility April 7, 2022
  • Bacterial Culture: Is It Time to Rethink the Gold Standard? March 28, 2022
  • Antimicrobial Resistance: The Human and Animal Connection March 17, 2022

Categories

  • Biologics Manufacturing
  • Biothreat Detection
  • Human Clinical Diagnostics
  • Investor Information
  • Product Information
  • Veterinary Diagnostics
  • Contact
  • Support
  • Privacy
  • Terms
  • Site Map

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA
info@lexagene.com | 800.215.1824

Subscribe for Updates
  • Follow
  • Follow
  • Follow
  • Follow

©2022 LexaGene All Rights Reserved